ITEAX
Price
$9.92
Change
-$0.00 (-0.00%)
Updated
Oct 7 closing price
Net Assets
287.89M
VIVAX
Price
$73.01
Change
-$0.09 (-0.12%)
Updated
Oct 7 closing price
Net Assets
207.8B
Interact to see
Advertisement

ITEAX vs VIVAX

Header iconITEAX vs VIVAX Comparison
Open Charts ITEAX vs VIVAXBanner chart's image
VY® T. Rowe Price Equity Income A
Price$9.92
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets287.89M
Vanguard Value Index I
Price$73.01
Change-$0.09 (-0.12%)
VolumeN/A
Net Assets207.8B
ITEAX vs VIVAX Comparison Chart in %
View a ticker or compare two or three
VS
ITEAX vs. VIVAX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ITEAX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 208B vs. ITEAX (288M). VIVAX pays higher dividends than ITEAX: VIVAX (1.97) vs ITEAX (1.36). ITEAX was incepted earlier than VIVAX: ITEAX (22 years) vs VIVAX (33 years). ITEAX (1.24) is less costly to investors than VIVAX (0.17). ITEAX is a more actively managed with annual turnover of: 21.00 vs. VIVAX (9.00). ITEAX has a lower initial minimum investment than VIVAX: ITEAX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 8.19 vs. ITEAX (-4.13). VIVAX return over 5 years is better than : 73.42 vs. ITEAX (28.75).
ITEAXVIVAXITEAX / VIVAX
Total Expense Ratio1.210.17712%
Annual Report Gross Expense Ratio1.240.17729%
Fund Existence22 years33 years-
Gain YTD-1.76810.738-16%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets288M208B0%
Annual Yield % from dividends1.361.9769%
Returns for 1 year-4.138.19-50%
Returns for 3 years17.1849.0835%
Returns for 5 years28.7573.4239%
Returns for 10 years-8.77132.94-7%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LZUSX18.14N/A
N/A
Lazard US Equity Focus Instl
NBHRX15.30N/A
N/A
Neuberger Berman Equity Income R3
WEMCX6.24N/A
N/A
Allspring Emerging Growth C
TRGOX95.58N/A
N/A
T. Rowe Price Lrg Cp Gr Inv
PAGYX22.84-0.10
-0.44%
Putnam Dynamic Asset Allocation Gr Y